Podcasts about Accreditation

Welcome back to the Law School Toolbox podcast! Today Alison is talking with the ABA's Managing Director of Accreditation and Legal Education about law school accreditation -- what's been happening in Texas and Florida, and what it means for current and prospective law students. In this episode we discuss: An introduction to our guest, Jennifer Rosato Perea What does law school accreditation actually mean? Changes to accreditation in Texas and Florida, and what they mean for students The portability of a law degree Choosing a law school in 2026 Resources: American Bar Association (https://www.americanbar.org/) Download the Transcript  (https://lawschooltoolbox.com/episode-565-law-school-accreditation-in-2026-a-conversation-with-jennifer-rosato-perea/) If you enjoy the podcast, we'd love a nice review and/or rating on Apple Podcasts (https://itunes.apple.com/us/podcast/law-school-toolbox-podcast/id1027603976) or your favorite listening app. And feel free to reach out to us directly. You can always reach us via the contact form on the Law School Toolbox website (http://lawschooltoolbox.com/contact). If you're concerned about the bar exam, check out our sister site, the Bar Exam Toolbox (http://barexamtoolbox.com/). You can also sign up for our weekly podcast newsletter (https://lawschooltoolbox.com/get-law-school-podcast-updates/) to make sure you never miss an episode! Thanks for listening! Alison & Lee

"Think about what organs lie in the radiation field, and anything that lies in that radiation field is likely going to have some potential temporary—hopefully temporary—side effects. If you think about the pelvis, the things that live in there are the bladder, urethra, some bowel, rectum, reproductive organs, skin, some lymph nodes. And so, all of those things could potentially have associated side effects," ONS member Kayla Kafka-Peterson, BSN, RN, ROCN™, nurse navigator and leader in the brachytherapy and peri-anesthesia programs at UCLA Health, in Los Angeles, CA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about radiation side effects in cancers of the pelvis. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 17, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to radiation to the pelvis. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Radiation Site-Specific Side Effects series Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles ONS Voice articles: Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: Nurse Navigation and Care During Brachytherapy for Cervical Cancer: 2025 ONS Bridge™ Session ONS ROCN™ Certification Review™ ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Genitourinary Distress: Common Side Effect Sexual Dysfunction: Common Side Effect Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers Oncology Nursing Forum article: Effect of Foot Reflexology and Aromatherapy on Anxiety and Pain During Brachytherapy for Cervical Cancer ONS Guidelines™ and Symptom Management Resources: Radiodermatitis Radiation-Induced Diarrhea Brachytherapy Huddle Card American Brachytherapy Society American Society for Radiation Oncology (ASTRO) European Society for Radiotherapy and Oncology (ESTRO) GEC-ESTRO Committee International Gynecologic Cancer Society Nursing Certificate Program To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Brachytherapy is delivered two main ways. The most common is LDR and HDR. LDR stands for low-dose-rate radiation, which is the older type of brachytherapy, but it is still very much practiced today. And it is where we put radioactive seeds directly into the tumor or tumor resection bed, depending on what you're treating. And those pieces of radioactive material, such as iodine-125 or palladium-103, those will give off radiation over time and treat the area that they are in, and they will place more or less seeds into the tumor, depending on that patient's needs and their anatomy." TS 3:26 "The most common [side effect] for external beam is bladder irritation—cystitis. It can be some burning, some frequency, some urgency, and it can often mimic a UTI [urinary tract infection]. We also have to make sure our patients do not have a UTI. Most of the time they don't, but we don't want to miss that. Once a UTI has been ruled out, the mucosa in the bladder and the urethra, it has a very high cell turnover rate. And things with a high cellular turnover rate like mucosal linings, they respond to radiation very quickly. They also heal very quickly, but they start to break down quite quickly during radiation." TS 16:15 "For the bladder, some things that we can teach the patients … to keep their urinary system as comfortable as possible during treatment. We really encourage hydration because the more hydrated they are, the more diluted their urine will be and the less acidic it will be. As those tissues start to respond to the radiation, they will become, for lack of a better word, a little bit raw. And if you think of something acidic going on something that is raw, it's going to burn, and these patients do get burning. And so by promoting hydration, their urine becomes less acidic; it doesn't burn as much when they do urinate. And I find a lot of patients who are experiencing the urinary side effects, they don't want to drink because they're afraid to urinate. And it actually makes the burning worse because their urine gets ultra-concentrated." TS 22:29 "Anybody who has a vagina, who receives treatment to the pelvis—it doesn't matter if it's for vaginal cancer or if it's for bowel or rectal—if they have received radiation to the pelvis, they are at risk for vaginal stenosis and adhesions. And this, of course, can be more pronounced in patients who have a higher dose in the vagina or a larger surface volume of the vagina treated. But over time, that tissue, even long after radiation is done, will undergo late changes where they will have continued scar formation, and it starts to lose its elasticity and its functionality. And at times it can stick to itself, causing these adhesions." TS 28:15 "I think a common misconception is that you cannot safely work around radiation. That is something that I have heard a lot. In certain regions of the world, the nurses actually report that they have been having trouble getting good applicants because nobody wants to work in radiation because they think that you'll get radiated, that it's not safe. We've really tried to make radiation safety a big part of our teaching to show that actually, you can safely work around radiation with today's technology." TS 41:43

Unlike most nations, the United States eschews centralized control over its system of higher education in favor of a more decentralized “regulatory triad” of accreditation agencies, state licensing authorities, and certification by the U.S. Department of Education to participate in federal student aid programs. To qualify for federal student loans and grants, colleges and universities must be institutionally accredited by an Education Department-recognized accrediting agency. As gatekeepers of federal financial aid, accreditors have great sway over their institutions. President Trump issued an executive order on "Reforming Accreditation to Strengthen Higher Education," and the Education Department recently commenced negotiated rulemaking on new accreditation regulations and intends to publish a final rule by November 1, 2026.But what is the purpose of accreditation, and how much power do accreditors hold? What is the connection to federal funding, and how are determinations of "academic quality" made? Do the current accreditation processes and recognized agencies meet their aims? What is the role of the Department’s National Advisory Committee for Institutional Quality and Integrity in this process? What can the public expect to see in the Department’s new accreditation regulations? To what extent, if at all, can the Department use its recognition authority over accreditors effectively to address such topics as campus free speech, academic freedom, DEI, and other controversial issues? Join us for a discussion on the nuts and bolts of accreditation and what the current process means for the state of higher education in America today.Featuring:Robert S. Eitel, Co-Founder and President, Defense of Freedom InstituteJonathan Helwink, Principal, Helwink Legal Group, PLLCAdam Kissel, Visiting Lecturer in Formal Organizations, Trinity College(Moderator) Sarah Parshall Perry, Vice President & Senior Legal Fellow, Defending Education

In this episode of the InspirED Podcast, Andrea De La Cerda explores the hidden grief that comes from feeling like you don't truly belong. Through deeply personal stories from her family, marriage, and corporate leadership journey, she shares how years of adapting to meet other people's expectations led to self-abandonment rather than authentic connection. Andrea explains the difference between fitting in and belonging, why so many women confuse performance with acceptance, and how loneliness often stems from hiding who we really are. This episode is an invitation to stop earning approval, reconnect with yourself, and build a life where belonging begins from within....CHAPTERS00:00 Why We Long to Belong 02:30 When Belonging Feels Conditional 05:15 How Self-Abandonment Begins 08:48 Searching for Acceptance 11:42 Fitting In vs. True Belonging 15:18 The Loneliness of Performance 18:41 What If the Problem Isn't You? 21:30 Learning to Belong to Yourself 25:02 Four Questions to Help You Reconnect 29:12 Choosing Yourself First...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠The InspirED RewriteTAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Congresswoman Mary Miller returns to the show to expand on her viral hearing exchange, declaring that medical schools abandoning basic scientific truth for DEI ideology should lose their accreditation entirely. She confirms the Smithsonian is being restored under the Trump administration after reports of pride flags replacing American flags in exhibits, and updates listeners on House Republicans pushing to get the SAVE Act, requiring voter ID, through a resistant Senate. Miller doesn't hold back, calling out Democrats for demanding photo ID to attend their own events while fighting it at the ballot box. Truth, accountability, and election integrity — that's Congresswoman Mary Miller on The Marc Cox Morning Show. Hashtags: #MarcCoxMorningShow #StLouis #ConservativeTalk #MaryMiller #SAVEAct #VoterID #MedicalSchoolAccountability #Smithsonian #DEI #ElectionIntegrity #FaithFamilyFreedom

"When we think of drug interactions, specifically, the National Cancer Institute actually defines this as a change in the way a drug acts in the body when taken with certain other drugs, herbals, or foods or when taken with certain medical conditions. Drug interactions may cause the drug to either be more or less effective or cause effects on the body that are not expected," Carissa Ganihong, PharmD, BCOP, oncology and bone marrow transplantation clinical pharmacist at Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about interaction pathways. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD), including 30 minutes of pharmacotherapeutic content, by listening to the full recording and completing an evaluation at courses.ons.org by July 10, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge related to drug interactions in oncology care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series ONS Voice articles: Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs? Pharmacogenomics Testing Helps to Ensure That Effective Therapy Is Safe Therapy Use of Herbal Products Carries Risk for Drug Interactions, but Patient–Clinician Knowledge, Communication Remain Low What the Research Says About Drug Interactions and Medical Cannabis ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) ONS Huddle Cards: DPYD Gene and DPD Enzyme Pharmacogenomics ONS Oral Anticancer Medication Toolkit American Journal of Nursing articles: Understanding Pharmacokinetics: Part1: Drug Absorption Understanding Pharmacokinetics: Part 2: Drug Distribution Understanding Pharmacokinetics: Part 3: Drug Metabolism Understanding Pharmacokinetics: Part 4: Drug Elimination Journal of Nuclear Medicine Technology articles: Pharmacology, Part 1: Introduction to Pharmacology and Pharmacodynamics Pharmacology, Part 2: Introduction to Pharmacokinetics ClinPGx To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "One of the most notable food interactions that interacts with many different medications is actually grapefruit or grapefruit juice. This is known to be a very strong CYP3A4 inhibitor. … A lot of medications are metabolized through the CYP3A4 pathway. By inhibiting the effect of these enzymes, that can actually increase and significantly increase the concentrations of these therapies. It's not an interaction that's just limited to grapefruit. I would say grapefruit being in the food interaction is kind of one of the most well-known, but it can also be seen with other foods as well, like pomegranate juice or a very specific type of orange called Seville oranges. And this is really just due to the presence of a substance called furanocoumarins." TS 6:12 "There have been a pretty large number of genes identified that are responsible for coding some of those common enzyme families that I had been discussing, some of those CYP450 enzymes, but other enzymes as well that are important for drug metabolism. Based on the type of gene, there could be some different categories where patients are normal metabolizers, intermediate metabolizers, or poor metabolizers. There are some other categories as well based on the type of gene we're looking at. And that can ultimately impact the way you are able to metabolize drugs." TS 15:56 "Another common [geneotypic variation] that we always think about in oncology is G6PD, where if someone has G6PD deficiency, these patients can be at greater risk of hemolytic anemias when receiving certain types of therapies. Dapsone and rasburicase are just a couple that have been associated with this risk." TS 17:50 "One of the big concerns is always polypharmacy. Our patients truly can be on a lot of medications. In the field that I work in, transplant, patients automatically from their transplant are on many, many different medications that can potentially predispose them to side effects. … But I think when it comes to the many drug interactions that may flag in these situations, we really have to look at the patient as a whole. Like, how long have these patients been on these therapies? Are they having side effects? Have they been on the combination for a very long time now? So I think that not just looking at the drug reference and seeing that there are like 10 different interactions flagged, but really assessing your patient as a whole can be very important—just because real-world practice, of course, is not black and white. It's often very gray, so it's just important to use clinical judgment in those scenarios." TS 26:10

On the July 10 edition: Georgia gets more federal aid for Hurricane Helene recovery; A brush fire continues to burn on Georgia's coast; And a new exhibit by artist Bobbi Johnson opening today in Milledgeville looks at how hard times shapes who we are. 

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with personal stylist Lizette Hendricks to challenge one of the biggest misconceptions women have about fashion: that clothing should fix their bodies. Lisette shares her philosophy of using style to honor a woman's natural features rather than hide or change them. Together, they explore body harmony, seasonal color analysis, style myths, wardrobe overwhelm, and the emotional connection many women have with clothing. Through practical advice and personal insight, this conversation invites women to stop chasing trends and start dressing in a way that reflects their authentic selves with confidence....CHAPTERS 00:00 Meet Lizette Hendricks 01:45 How Lizette Became a Personal Stylist 03:23 Why Traditional Fashion Advice Falls Short 05:11 Creating a Safe Space for Style 07:14 Body Harmony, Color, and Personal Style 11:15 Why Style Is About Authenticity 13:00 Stop Dressing to Fix Your Body 17:10 The Freedom of Dressing as Yourself 18:38 Understanding Body Types and Color Seasons 24:40 Common Style Myths Debunked 27:52 Simplifying Your Wardrobe with Confidence...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Connect with Lizette Andrea De La Cerda⁠⁠Business Audit⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Cameron is joined by Tom Terranova, CEO of QUAD A, and they discuss the critical theme of compliance in the medical aesthetics industry. They explore the evolving landscape of regulations, the importance of accreditation, and how practices can enhance patient safety and trust through compliance. They highlight the need for a structured approach to compliance, emphasizing that it is not merely a checkbox but a continuous process of improvement and accountability. Tom shares insights on how QUAD A supports practices in achieving and maintaining high standards, ultimately benefiting both providers and patients.Cameron and Tom talk about the evolving landscape of medical aesthetics, focusing on the importance of patient trust, compliance, and accreditation. They explore the common deficiencies in medical practices, the accreditation process, and the potential impact of AI on healthcare. They also emphasize the need for practices to adapt to changing regulations and patient expectations while maintaining high standards of care. Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:Compliance is essential for safety and regulation in medical aesthetics.The wellness industry is at a pivotal moment for maturation.Patients should be treated as individuals, not just consumers.Accountability and continuous improvement are key aspects of compliance.A compliant practice is characterized by thoughtful and intentional operations.Standards for compliance are evolving as the industry grows.Optimizing operations is as important as meeting compliance standards.Patients value impartial accreditation as a sign of quality.Compliance should be viewed as an ongoing process, not a one-time checklist.Practices should aim to compete on quality rather than just price. Patients prioritize safety, results, compliance, and trust in their healthcare.The rise in popularity of aesthetic treatments has led to increased adverse events.Accreditation significantly boosts patient trust and confidence in medical facilities.Many patients remain unaware of the benefits of elective wellness treatments.Documentation is the most common deficiency in medical practices.The accreditation process typically takes around five months for facilities.Accreditation may soon become a standard expectation in the industry.Legislation regarding medical aesthetics is on the horizon.AI has the potential to enhance compliance but must be used cautiously.Practices need to differentiate themselves to thrive in a saturated market.Medical Millionaire: The Blueprint for Scaling a World-Class Medical Aesthetics PracticeWelcome to Medical Millionaire, the go-to podcast for forward-thinking Medspa owners, Medical Aesthetics leaders, Plastic Surgery & Dermatology practices, Concierge Wellness clinics, and Elective Healthcare entrepreneurs who are ready to scale with intention and operate like a true, high-performing business.If you're building, growing, optimizing, or preparing to exit your aesthetics or wellness practice, this show is your competitive advantage.Hosted by Cameron Hemphill Your Guide to Sustainable, Scalable Growth Your host, Cameron Hemphill, is one of the most trusted growth strategists in Medical Aesthetics and Elective Wellness.With over 10 years in the industry, Cameron has helped scale 1,000+ practices and more than 2,300 providers, working alongside the most recognized KOLs, national brands, EMRs, tech companies, and private equity groups, shaping the future of aesthetics. From marketing to operations, from finance to leadership, Cameron brings a real-world, data-driven perspective on what it takes to turn a practice into a powerful business engine.What This Podcast Is All About: Each episode takes you behind the scenes of the fastest-growing practices in the country, revealing the systems, strategies, and mindset required to win in today's Medical Aesthetics landscape.Expect tactical insights, step-by-step frameworks, and conversations with:Industry thought leadersTop injectors & medical directorsEMR & tech innovatorsOperations expertsMarketing strategistsPrivate equity & M&A advisorsWellness and longevity pioneersThis is where aesthetics, business, technology, and wellness converge. What You'll Learn on Medical Millionaire Every week, you'll access expert guidance to help you scale profitably and predictably, including:Marketing & Brand PositioningCRM + Lead Management SystemsPatient Acquisition & ConversionEMR Optimization & Tech Stack ArchitectureSales Psychology & Consultation MasteryFinance, KPIs, and Practice EconomicsOperational Workflows & AutomationIndustry Trends Backed by Real Benchmark DataPatient Retention & Lifetime Value ExpansionMindset, Leadership & Team DevelopmentWhether you're opening your first location or running a multi-million-dollar enterprise, you'll gain the clarity and direction to grow with confidence. A Show Designed for Every Stage of Practice Growth Medical Millionaire breaks down the journey into four essential stages, showing you exactly how to move from one to the next:Startup – Build the foundation and attract your first wave of patientsGrowth – Scale revenue, expand services, and strengthen operationsOptimize – Increase efficiency, margins, and customer experienceExit – Prepare your practice for maximum valuation and acquisitionIf You're Ready to Grow, This Is Where You Start. Tune in weekly for actionable insights, expert interviews, and the exact playbooks high-performing practices use to dominate their markets. This is the podcast for Medspa owners who want more than a job; they want a scalable, profitable, industry-leading business. Welcome to Medical Millionaire.Let's build your practice into the empire it deserves to be.

"What I appreciate about our patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia is the consideration that they receive a cancer diagnosis, and the best thing for them to do is actually nothing. There is a large population of patients that we don't recommend any type of treatment. We recommend that they establish care with an oncologist and that they have a relationship with those care teams," ONS member Caitilin Murphy, DNP, APRN, FNP-BC, AOCNP®, chief nurse practitioner at Dana-Farber Cancer Institute in Boston, MA, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about an overview of CLL for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by July 3, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge of the diagnosis and management of chronic lymphocytic leukemia. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 256: Cancer Symptom Management Basics: Hematologic Complications ONS Voice articles: Compensation Funds Curb Financial Burden for Certain Exposure-Related Cancers Infection Prevention for Oncology Nurses Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment Patient Stress Linked to More Advanced Leukemia Patients With CLL Report Worse QoL and Other Factors Clinical Journal of Oncology Nursing articles:  Care Coordination: Overcoming Barriers to Improve Outcomes for Patients With Hematologic Malignancies in Rural Settings Pseudohyperkalemia in Chronic Lymphocytic Leukemia: An Often Overlooked Clinical Entity Richter Transformation Arising From Chronic Lymphocytic Leukemia ONS book: Site-Specific Cancer Series: Leukemia (first edition) Hematology, Cellular Therapy and Stem Cell Transplantation Learning Library ONS Biomarker Database ONS clinical practice resource: Genomics Taxonomy Blood Cancer United: Chronic Lymphocytic Leukemia: In Detail CLL Society: Patient Education Toolkit Lymphoma Research Foundation: Lymphoma and CLL Publications National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the common risk factors are environmental exposures, occupational exposures, and chemical exposures. For example, in certain farming communities where there are pesticides, that can definitely contribute to the risk of developing CLL. There's some consideration for high levels of radon exposure or exposure to Agent Orange. So our veterans, both from the Vietnam War but also more recently in Iraq. There's definitely a consideration that those types of exposures increase the risk of developing CLL." TS 3:01 "Generally, the average age of diagnosis for CLL is in the seventh decade of life. But over 90% of people are diagnosed at age 50 and above. So, this tends to be a diagnosis in the six or seventh decade of life. It's extremely rare in children, although it has been observed, and it's twice as likely to develop in men than it is compared to women. And then individuals who are White are more frequently affected by CLL than other racial or ethnic groups, followed by people of color. And that includes Black, Hispanic, and Native American individuals, but it's rarer in Asian populations." TS 9:33  "There's a lot of adjustment and coping with a new diagnosis. When we think about the diagnostic approach, we get a lot of information that's incredibly valuable and helps us really to pivot and guide patients as to where they need to go and how we can best support them. We've had well-established studies that look to say, 'If we were to treat patients earlier or have different thresholds for consideration for treatment, do patients do better?' ... I think it's really great that we can actually guide patients in a much more precise way, that you don't need any type of therapy at this point, and it may change and evolve in the future." TS 20:29 "I have some patients that are doers and they want to do something, so this active surveillance or watch and wait really paralyzes their coping. And so they want to do something. Oftentimes, that's really when I pull in some integrative strategies and say exercise is always going to be beneficial. The more active you are, the more physically fit you are. If you really want to do something, make sure that you stay hydrated, that you eat well, and you're engaged in a physical activity that you enjoy and can be consistent with." TS 32:37 "I think another piece that we don't often discuss is around the immunoglobulins and the immune system, but CLL has a pretty significant impact on immune dysfunction. And so patients with CLL, even if they are not on any type of active treatment, their immune system doesn't necessarily function fully. And so they're more likely to develop some upper respiratory infections or more easily develop the flu or coronavirus. ... Often times, we think a lot about supporting patients to get vaccines and to have early evaluation if those symptoms develop because you're more likely to develop upper respiratory infections. I think there's a component around immune dysfunction that I think is really valuable for people to understand that it's not contingent upon the treatment. It's contingent upon the disease and mechanistically, how the B cells are dysfunctional and don't provide that immunity that otherwise would be in a healthy B cell." TS 42:54

In this episode of the InspirED Podcast, Andrea De La Cerda explores why so many women struggle with negotiation and why the challenge has less to do with confidence than with lifelong conditioning. She explains how women are often taught to prioritize likability over self-advocacy, making it difficult to negotiate compensation, pricing, boundaries, and opportunities. Andrea reframes negotiation as a conversation about alignment rather than confrontation and shares practical strategies to communicate value with greater clarity, confidence, and authority. Whether you're negotiating your salary, setting business rates, or advocating for your role, this episode offers actionable insights to help you stop shrinking and start leading....CHAPTERS00:00 Why Women Hesitate to Negotiate 02:12 The Conditioning Behind Self-Advocacy 05:04 Why Likability Feels Safer Than Respect 07:46 The Hidden Cost of Staying Quiet 10:18 Negotiation Is About Alignment, Not Conflict 12:30 Four Practical Ways to Start Negotiating 16:42 Building Confidence Through Self-Advocacy 19:03 The Long-Term Impact of Speaking Up...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Neal Shah, Shareholder, Polsinelli, speaks with Scott Strickland, Attorney, Hall Render Killian Heath & Lyman PC, about what the Center for Medicare and Medicaid Innovation (CMMI) has been doing in the health care space. They discuss examples of some of the more prominent CMMI models, the distinction between CMMI models and traditional CMS models, health care industry responses to CMMI models, what the next generation of CMMI models looks like, and the different approaches that CMMI has taken regarding provider payment obligations. Scott co-authored an article for Health Law Connections on this topic. From AHLA's Regulation, Accreditation, and Payment Practice Group.Watch this episode: https://www.youtube.com/watch?v=bQysibh0rhYRead Scott's Health Law Connections article: https://www.americanhealthlaw.org/content-library/connections-magazine/article/34b68117-81e2-4c7f-9258-245198a69107/CMMI-and-the-Next-Generation-of-Alternative-Paymen Learn more about AHLA's Regulation, Accreditation, and Payment Practice Group: https://www.americanhealthlaw.org/practice-groups/practice-groups/regulation-accreditation-and-payment Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

Send us Fan MailWelcome to The BTA Podcast.  In these podcasts we will endeavour to share our thoughts, concerns, optimism and build those all-important human connections with our Partners, Members and Guests.Episode Overview:The latest edition of the BTA Pulse reflects on the momentum following the Business Travel Show, where the BTA launched its new Accreditation programme — a significant step forward in recognising professionalism, standards and best practice across the business travel sector. Andrew and Clive discuss the strong response from members, buyers and suppliers, alongside the wider conversations shaping the industry.The episode explores the BTA's ongoing work bringing all industry sectors together, from aviation and rail to hotels, sustainability and talent development. Key topics include improving industry processes, strengthening collaboration, supporting future travel professionals through Generation BTA, and addressing challenges around safety, technology and changing travel requirements. The latest BTA Pulse highlights the association's continued commitment to driving positive change across the business travel ecosystem.You can subscribe to this podcast by searching 'BusinessTravel360' on your favorite podcast player or visiting BusinessTravel360.comThis podcast was created by The BTA and edited & distributed by BusinessTravel360.  For more information about The BTA visit TheBTA.org.ukSupport the show

"There are a huge array of medical dynamics that people endure, and when they leave a lasting impact, a word that we don't use widely enough is the word 'trauma.' There's an entire category of phenomena in the medical arena that are, in fact, traumatic. One way we know that these experiences are traumatic is that we know that huge portions of people who experience things like cancer do indeed develop problems like [post-traumatic stress disorder]," James C. Jackson, PsyD, research professor at Vanderbilt University Medical Center in Nashville, TN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about understanding medical trauma in oncology. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 26, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report increased knowledge of medical trauma and its effects on patients with cancer, caregivers, and healthcare professionals. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 315: Processing Grief as an Oncology Nurse Episode 287: Tools, Techniques, and Real-World Examples for Difficult Conversations in Cancer Care Episode 276: Support Young Families During a Parent's Cancer Journey Episode 257: Redefining the Bell: The Ethics of Hope for Oncology Nurses and Patients Episode 103: What Oncology Nurses Need to Know to Support Caregivers ONS Voice articles: 'Between Two Kingdoms' Gives Us a Glimpse Into How Patients and Families Experience Malignancy AYA Cancer Survivors Experience Five Times Higher Depression Rates Than Individuals Diagnosed at Older Ages From Stigma to Support: Changing the Cancer Conversation Help Caregivers Control the Chronic Stress of Cancer Care and Manage PTSD Moral Injury and Trauma in Nursing Trauma-Informed Care Provides Person-Centered Support for Patients During Deep Distress When the Story Ends, Cancer Does Not Win: Reframing Death in Terminal Cancer Care Word Choice Matters When Caring for Patients With Cancer ONS course: ONS Psychosocial Dimensions of Cancer Care™  Clinical Journal of Oncology Nursing articles: Psychosocial Barriers to Care: Recognizing and Responding Through a Trauma-Informed Care Approach Trauma-Informed Care Addressing the Mental and Emotional Needs of Patients With Cancer Oncology Nursing Forum articles: Post-Traumatic Distress and Symptom Experience in Patients With Head and Neck Cancer–Related Tracheostomy and Family Caregivers The Effect of Neuroticism, Fear of Progression, and Self-Efficacy on Post-Traumatic Growth in Patients With Lung Cancer Undergoing Chemotherapy Reclaiming Your Life From Medical Trauma by James C. Jackson To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Many people have a notion about what medical trauma is, but perhaps they lack a definition. I use a definition that is deliberately broad because I think it is better to be inclusive than exclusive. A medical trauma to me is a medical experience or a medical encounter that basically leaves a mark. It leaves an emotional mark, and that mark is significant enough to disrupt your daily life." TS 2:06 "When somebody develops a life-threatening illness—let's say cancer—it's not their problem only. It's very much a family problem. It affects any manner of people. There is literature that says that family members of people with life-threatening conditions often have rates of PTSD that are every bit as high as the patients do. There's also literature that says that if we can identify this issue as a family problem—a family challenge, not just an individual challenge—then very often that patient is going to do better." TS 8:23 "We just need to make space for people to feel however they feel. And we need to emphasize, I think, that in some ways, even though there's no cancer on the scan, cancer casts a long shadow in the lives of people, which is why when patients after cancer see their primary care provider, when they come back for a checkup with oncology, we need to continue this conversation of 'How is your mental health? Are you okay? How's your anxiety? How are you managing?' … We need to be really curious and kind, and we need to query people about how they're doing, even if officially they don't have cancer." TS 16:20 "Trauma-informed care has become a bit of a buzzword in our culture. But when it is engaged correctly, I think it's really important. And I think in a nutshell, what it means is that as providers, we need to recognize that some situations and circumstances are likely to be traumatic, and we need to pivot and engage people differently now that we know that. Specific features of trauma-informed care might be we're really going to value your emotional safety. We're going to emphasize that. We are going to emphasize boundaries. We are going to ask your permission instead of telling you how to do things. We are going to be really attentive to the language we use to engage you because we're aware of there might be things about your situation that are really triggering." TS 28:15 "I think one [misconception] certainly is that it is only afflicting and affecting people who are frail or weak—not very strong. That's emphatically not true. But that's a popular misconception—that if I'm strong enough, if I'm resilient enough, this experience will not be traumatic to me. It's just not true. Medical trauma doesn't just happen in emotionally weak people. Medical trauma can impact people of all sorts." TS 33:42 "The other misconception, I think, is that there is no hope for people in the throes of medical trauma. I'm not advocating 'hopium,' It's a term that was coined, I think, during the pandemic. I don't think that living with medical trauma is all rainbows and unicorns and shiny things. But the truth is, if you get the treatment that you need, you can find a way to thrive with medical trauma even as you're impacted by medical trauma. This, this 'both-and-ness' is really true. You can both be adversely affected and you can even find some beauty in your struggle. Both can be true." TS 34:13 "I wish people understood that there is a name for this phenomenon. We're naming it here today medical trauma. Not everyone who has cancer has medical trauma—not even close—but there are many people who do. And I think many of those people, they don't quite have a name for it. And when I introduce this name for it—trauma—many of them say, 'Oh, my gosh, that makes so much sense. I didn't quite understand why I was struggling so much with this. I didn't quite understand why it casts such a long shadow in my life. I didn't really understand why I was having panic attacks every time I had to get another scan at the oncology office to see if my breast cancer had returned. Now I understand. Now I understand it's because it was trauma.'" TS 35:09

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with Ashley Crossan to discuss her remarkable journey from chronic illness to holistic healing practitioner. After years of battling serious health challenges, including chronic illness, long-haul COVID, and Lyme disease, Ashley began exploring holistic health, emotional healing, and energy work in search of answers beyond symptom management. Together, they explore the connection between emotional well-being and physical health, the role of unresolved stress and trauma in the body, and how healing can become a catalyst for personal growth and purpose. This conversation offers an inspiring perspective on resilience, wellness, and finding meaning through life's most difficult experiences....CHAPTERS 00:00 Meet Ashley Crossan 01:37 Ashley's Journey Through Chronic Illness 04:48 Long-Haul COVID, Lyme Disease, and Healing 06:15 Discovering Holistic Health and Energy Work 08:05 Understanding Energy and Emotional Healing 10:41 The Connection Between Pain and Unresolved Emotions 13:48 Why More People Are Exploring Alternative Healing 16:10 Stories of Transformation and Recovery 19:59 From Skeptic to Believer 23:51 The Science Behind the Mind-Body Connection 26:03 Healing Beyond Symptom Management 27:20 How to Connect with Ashley...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Connect with AshleyAndrea De La Cerda⁠⁠Business Audit⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

In this episode, ASOPRS Immediate Past President, Dr. Wendy Lee, moderates a candid roundtable with Drs. Don Kikkawa, John Holds, Evan Black, and Reza Vagefi, as they discuss ACGME accreditation of fellowship training. The panel weighs external validation, standardized training, and the potential for a new ABO subspecialty certification in the setting of ACGME requirements and some program director concerns about those requirements. Both ACGME accreditation of fellowships and participation in ABO Continuing Certification are two key components of an ABMS-compliant certification. Whether you're a member or simply invested in the future of oculofacial plastic surgery, this conversation is essential listening.

Send us Fan Mail00:00 Brought to You by TAB Quartz00:19 Intro00:29 April U.S. Hard-Surface Imports03:35 A Word from TAB Quartz 04:44 2025 China Stone Exports07:36 Marmomac Turns 6009:36 NSI Accreditation at 20th11:35 IPS Labs Handle New ANSI Tile Standard14:03 NSI Offers 5 New Webinars15:26 Outro15:54 Brought to You by TAB QuartzRadio Stone Update is presented on the second and fourth Wednesdays every month at 9 a.m. everywhere on Earth with the latest news and insights in hard surfaces. Check our archives at www.radiostoneupdate.com.

"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN®, nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 220: Oncologic Emergencies 101: Febrile Neutropenia and Sepsis Clinical Journal of Oncology Nursing articles:  Exploring Experiences of Bereaved Caregivers of Older Adult Patients With Acute Myeloid Leukemia Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Oncology Nursing Forum article: An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies ONS book: BMTCN® Certification Review Manual (second edition) ONS course: Psychosocial Dimensions of Cancer Care™  ONS Learning Libraries:  Survivorship Learning Library Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship Care Plan Huddle Card American Association of Colleges of Nursing End-of-Life Nursing Education Consortium (ELNEC) American Cancer Society: Living As a Myelodysplastic Syndrome Survivor American Society of Hematology Aplastic Anemia and MDS International Foundation: MDS Toolkit Blood Cancer United: Myelodysplastic Syndromes Family Caregiver Alliance HealthTree Foundation Inspire: MDS Support and Discussion Community Myelodysplastic Syndromes Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "When our higher-risk patients have disease-related progression, their [malignancy] can transform to AML. And we know this occurs in about one-third of our patients and is one of the most serious late effects. Even in lower-risk disease, we have this worsening marrow failure with or without increasing blast, where [patients] may have just started out with anemia, then they also develop neutropenia and thrombocytopenia. And as those counts worsen, we usually know that their disease is progressing." TS 2:47 "The golden rule is looking at the blood count but also looking at the patient and how they're doing over time. The backbone of MDS monitoring is the complete blood cell count with the differential. What you're looking for is trends over time. How many units of blood are they receiving, what threshold are you going to transfuse them at, and how many units of blood are they getting at a time? ... And then paying attention to the absolute neutrophil count for infection risk. [Another] really important piece of when you look at the differential with patients is seeing if they have any abnormal cell counts. Do they have circulating blasts? Are those monocytes going up? If you start to see blasts circulating or increasing monocytes, then their disease could be changing, even if they have low-risk disease." TS 15:58 "For lower-risk disease, we're paying more attention to their quality of life, how the patient's tolerating therapy, trying to help them stay safe over the long haul, and starting them on iron chelation if it matches that patient and they can have access to those drugs. ... For higher-risk disease, if the patient's goal is to be cured and not to progress to AML, you want to get them to transplant if that's [also] one of their goals. If they do evolve into AML, try and see what treatment matches best for them." TS 22:28 "You want to start early for patients who have febrile neutropenia—that's really important when a patient is an hour or two away from a center where they can get started on antibiotics. So, you have to think outside the box. What can we do to keep them safe? ... I know this group in Alaska that's in our advisory meetings and they try to facilitate transportation to Seattle. That's the closest academic center to them. Collaborating with telemedicine appointments, starting earlier, developing that strong relationship with patients, and contacting them between visits [can help patients living in rural areas]." TS 25:22 "I think the biggest [psychosocial challenge] I see is a lot of unmet anxiety and depression counseling. A lot of times, [patients are] losing their place in their family because they're the ones that need all the help now. Also, the uncertainty that goes along with the diagnosis. There is communication skills counseling, and End-of-Life Nursing Education Consortium (ELNEC) has a lot of training for communication skills and how to really talk to patients. Not that we take the place of a psychologist, but just being able to talk to somebody can go a long way. And if we can get training for that, we can help more patients." TS 31:15

On today's program, the Assemblies of God is disputing liability in abuse cases — claiming local church autonomy shields it from the Daniel Savala sex abuse lawsuits. And, a movement to void nondisclosure agreements in cases of child sexual abuse is gaining ground — on both the local and national levels. The laws limiting NDAs are called Trey's Laws. We'll take a look. Plus, Southwestern Baptist Theological Seminary, has, after years of turmoil, officially regained its accreditation status. But first, Sean Feucht Ministries is fighting back against a lawsuit — and it’s using the First Amendment to do it. It argues a $250,000 lawsuit filed against it should be dismissed because of what’s called the “church autonomy doctrine.” It protects religious institutions from lawsuits that would require courts to wade into matters of faith and doctrine. The producer for today's program is Jeff McIntosh. We get database and other technical support from Stephen DuBarry, Rod Pitzer, and Casey Sudduth. Writers who contributed to today's program include Kim Roberts, Stacey Horton, Marci Seither, Makella Knowles, and Jessica Eturralde. Until next time, may God bless you.  

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with Gina Fedeli, founder of P3 Transformation, to explore the powerful connection between identity and leadership. Drawing from her experience leading large teams in male-dominated industries and advising founders and CEOs, Gina shares how self-awareness, values alignment, emotional intelligence, and communication shape the way leaders show up and influence others. Together, they discuss the CEO-COO partnership, intuition in leadership, understanding the whole person, and why meaningful leadership starts with knowing yourself first. This conversation offers valuable insight for entrepreneurs, executives, and emerging leaders who want to lead with greater authenticity, clarity, and impact....CHAPTERS00:00 Meet Gina Fedeli 02:20 Leading in Male-Dominated Industries 04:05 Learning to Meet People Where They Are 05:58 Why Great Leaders Understand the Whole Person 09:16 Intuition, Self-Awareness, and Leadership 13:36 Emotional Intelligence in Business 16:44 The CEO and COO Partnership 18:33 Leadership, Identity, and Founder Growth 22:21 Values Alignment and Organizational Culture 26:59 What Meaningful Leadership Looks Like 29:45 Advice for Women Leaders...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠P3 Transformation Gina FedeliAndrea De La Cerda⁠Business Audit⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

"Until immunomodulators, patients [with myeloma] did not have a great overall survival rate. But when we introduced lenalidomide, we started seeing our patients have life expectancies between five and seven years—which was unheard of prior to these immunomodulators going forward. I think it's promising and allows patients to have quality of life versus therapy of life," ONS member Daniel Verina, DNP, RN, ACNP-BC, nurse practitioner for the multiple myeloma program at Mount Sinai Medical Center in New York, NY, told Lenise Taylor, MN, RN, AOCNS®, BMTCN®, oncology clinical specialist at ONS, during a conversation about immunomodulators. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 12, 2027. Daniel Verina is on the speakers' bureau for Johnson & Johnson, GlaxoSmithKline, and Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome:  Learners will report an increase in knowledge about the use of immunomodulators to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 386: Interprofessional Navigation and the Oral Anticancer Medication Care Compass Episode 290: Cancer Symptom Management Basics: Peripheral Neuropathy ONS Voice articles: Maintain Oral Adherence With ONS Guidelines™ Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Sexual Considerations for Patients With Cancer Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum articles: Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Symptom Intervention resource: Peripheral Neuropathy Risk Evaluation and Mitigation Strategies (REMS) Lenalidomide Pomalidomide Thalidomide International Myeloma Foundation: Using Immune Therapy to Fight Multiple Myeloma International Myeloma Society Multiple Myeloma Research Foundation: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We definitely want the diagnosis of multiple myeloma before initiating these drugs. We're going to look at serum protein electrophoresis. We want to make sure that we know the patient has serum free light chains and myeloma proteins to really confirm their disease. Plus, a bone marrow biopsy." TS 7:21 "Each immunomodulator has slightly different side effects. Thalidomide's biggest side effects are constipation, weakness, fatigue, somnolence, peripheral neuropathy, mood swings, hand tremors, and depression. With each generation, less of the side effects actually occurred. Most of lenalidomide's side effects, not discounting the deep vein thrombosis, are pancytopenia—the neutropenia, the anemia, and the thrombocytopenia. [The side effects] are very similar in pomalidomide." TS 15:40 "The REMS program is critical for oral immunomodulator therapies—thalidomide, pomalidomide, and lenalidomide. It was developed due to the risk of developing embryofetal toxicities. ... It is mandatory testing and counseling, so all females of reproductive potential must have two negative pregnancy tests prior to starting the therapy and then monthly pregnancy tests while on the therapy alone. Again, they must use two forms of effective contraceptives or abstain from heterosexual sex four weeks prior, during, and after. And the same thing for men. I focus on that because males may say, 'I have a vasectomy.' These therapies tend to bind to the semen. So, males must still use a latex or synthetic condom during any sexual contact with a female of reproductive potential, even if they did have a vasectomy." TS 18:31 "The capsule itself cannot be chewed, crushed, or opened. I bring that up because as healthcare professionals, we have educated our patients. If it's difficult to swallow capsules or tablets, we've always said to them, 'Oh, don't worry, just crush it into applesauce or open it up and sprinkle it on your mashed potatoes.' But because of this embryofetal toxicity, I advise my patients not to open the capsule. If they can't swallow it for any reason, they have a sore throat or they're just unable to, then [we tell them] to hold the therapy and then call us." TS 22:49 "We spoke about three generations already, but there's actually a fourth generation [of immunomodulators]. They're called cereblon E3 ligase modulators(CELMoDs). They're still in clinical trials but really showing promise in the therapy of myeloma. They're showing very good affinity to cereblons, just like the immunomodulators do. I think, in all cancer therapies, as newer generations come out or newer therapies move forward, some of the older generations might move aside, but they get integrated later on. So I don't think [immunomodulators] will disappear totally, but they will probably be modified." TS 36:39

Send us Fan MailIn this episode of NATA-Cast, hosts Mollie Pillman, MS, MBA, CAE, and Katie Scott, MS, ATC, CAE, welcome Brian Conway, LAT, ATC, and Anne Minton, MBA, ICE-CCP, from the Board of Certification for the Athletic Trainer (BOC) to explore how certification processes continue to evolve through changing accreditation standards, new technologies, and a commitment to maintaining best practices. Brian and Anne also provide an update on the Athletic Trainer Compact, including its development, current legislative progress, and what athletic trainers need to know about obtaining compact privileges. The episode covers continuing professional certification resources such as Pathfinder and the new Sync CE platform, while also highlighting broader industry priorities, including workforce recruitment and retention, collaboration across the profession, and the future direction of athletic training.NATA-Cast is produced by Association Briefings. Follow The National Athletic Trainers' Association on social media!FacebookXInstagramLinkedInHave an idea for an episode or series? Send us an email! thenatacast@nata.org

In this episode of the InspirED Podcast, Andrea De La Cerda challenges the belief that women are "too much" and explores how cultural conditioning teaches many women to shrink themselves to maintain acceptance and harmony. Drawing from personal experience, leadership research, neuroscience, and behavioral psychology, Andrea explains why visibility can feel unsafe, how self-silencing affects confidence and income, and why taking up space is often a nervous system challenge rather than a capability issue. She shares practical strategies for trusting your intuition, setting boundaries without over-explaining, and reclaiming your authority in business and life. This episode is a powerful invitation for women to stop editing themselves and start leading from their full presence....CHAPTERS00:00 A Moment of Self-Abandonment 02:12 The Belief That You're Too Much 04:38 How Girls Are Taught to Stay Small 07:14 Why Visibility Feels Unsafe 10:22 Trusting Your Intuition Over Approval 13:48 The Cost of Over-Explaining 17:05 Taking Up Space and Owning Your Authority 20:11 Practical Ways to Stop Shrinking 23:02 The Ripple Effect of Visibility...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business AuditTAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠⁠...CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

CMS is reshaping DMEPOS accreditation. Learn what the shift to annual surveys means for ABC accredited facilities in 2026, what stays the same, and how to prepare for a year round, survey ready approach.

Innovations in Islet Cell Research   Evaluation and Credit:  Evaluation and Credit:  https://www.surveymonkey.com/r/medchat91   Target Audience             This activity is targeted toward primary care physicians and advanced providers.   Statement of Need  The purpose of this podcast is for physicians and clinicians to gain a deepening understanding of pancreatic islet cell transplantation research and its application for the treatment of chronic pancreatitis as well as future treatment of Type 1 diabetes.   Objectives  1.     Explain the role of pancreatic islet cells and their function in glucose homeostasis and insulin regulation. 2.     Discuss emerging research and investigational advances in islet-cell therapies. 3.     Differentiate allogenic, xenogenic and autologous islet cell transplantation, as well as islet cell transplantation via stem cells in the management of chronic pancreatis and Type 1 diabetes.   Moderator Mark McDonald, M.D., MHA, CPE System Vice President Pediatric Medical Affairs Medical Director, Norton Children's Louisville, Kentucky   Professor Department of Pediatrics Division of Critical Care UofL School of Medicine Louisville, Kentucky   Speaker Balamurugan Appakala, Ph.D. Norton Islet Cell Research and Transplant Program Director Wendy Novak Diabetes Institute, a part of Norton Healthcare and Norton Children's Professor of Pediatric Endocrinology UofL School of Medicine   Planners, Moderator and Speaker Disclosure   The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.   Commercial Support   There was no commercial support for this activity.    Physician Credits Accreditation  Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.   Designation  Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.     For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/References Islet cell transplantation in children https://pubmed.ncbi.nlm.nih.gov/32571510/   Current status of pancreatic islet xenotransplantation https://pubmed.ncbi.nlm.nih.gov/39924969/   Date of Original Release | June 2026; Information is current as of the time of recording.  Course Termination Date | June 2029 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope.   Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

"Radiation therapy is often extremely well tolerated in colorectal cancer. Technology has really changed things. But location of the tumor can affect side effects, such as radiation dermatitis. If a patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case," ONS member Lorraine Drapek, DNP, FNP-BC, AOCNP®, nurse practitioner in the Department of Radiation Oncology at Massachusetts General Hospital in Boston, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation side effects in colorectal cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 5, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat colorectal cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 374: Colorectal Cancer Treatment Considerations for Nurses Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer High-Fiber Diet Reduces Diarrhea in Colorectal Cancer Survivors Hyperbaric Oxygen Therapy Shows Promise for Certain Radiation Side Effects Increasing Incidence of Colorectal Cancer in Younger Adults Is a Call to Action for Oncology Nurses Oncology Drug Reference Sheet: 5-Fluorouracil Oncology Drug Reference Sheet: Oxaliplatin Oncology Nurses Are Key in Sexual Health Conversations With Minority Women Sexual Considerations for Patients With Cancer The Intersection of Pelvic Health and Oncology Optimizes Sexual Symptom Management ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS ROCN™ Certification Review™ Clinical Journal of Oncology Nursing articles: Sexual Dysfunction: Common Side Effect Updated Interventions for Radiation-Induced Diarrhea: Putting Evidence Into Practice With the Oncology Nursing Society Physical Activity: A Systematic Review to Inform Nurse Recommendations During Treatment for Colorectal Cancer ONS Learning Libraries: Colorectal Cancer Radiation Advanced Practitioner Society for Hematology and Oncology American Society for Radiation Oncology American Society of Clinical Oncology Clinical Practice Guidelines Colontown Colorectal Cancer Alliance To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "In recent years, there has been more nonsurgical management of rectal cancer, especially in what we call the low-lying population. This is the population of patients who would likely end up with a permanent colostomy because their cancer is so low in terms of being close to or involving the anal verge. There is now a regimen where these patients can get their chemotherapy followed by their chemoradiation and then be monitored on close surveillance without surgery." TS 2:23 "Another assessment would be to assess what effects have they had from their chemotherapy that they're bringing with them. FOLFOX-based treatment is commonly used, and the platinum therapy oxaliplatin often causes peripheral neuropathy. What is the patient having? What are those symptoms like? Are they having peripheral neuropathy? If they are that is likely not going to get better or improve during their whole course of radiation. In fact, sometimes when oxaliplatin therapy stops, the peripheral neuropathy can get worse as patients are going through other treatments." TS 5:42 "If the patient has a low-lying tumor, if it's less than six centimeters from the anal verge, the patient is likely to have some skin reaction. It's good to be proactive if that's the case. And then proactively minimizing radiation dermatitis effects, such as keeping the area clean, good washing of the area, and prophylactically starting them on or having someone start them on steroid creams a couple of times a day to minimize that radiation dermatitis effect in the long run." TS 7:25 "I have a sexual health clinic for women with these effects. It's very important as nurses that if you can develop the comfort to ask patients about their sexual activity—it's hard, but it really needs to be done. And I will tell you that the healthcare providers are not doing it. They don't have time, and like us as nurses, we don't get this in school, and neither do they. The other providers don't get it in school either, but it's important. Patients are getting more and more worried about their sexual health. They're coming to us at a younger age, and this is really, really important to address." TS 15:35 "I would say that working with your advanced practice providers and education for advanced practice providers has definitely been focusing on [sexual health] more. Your PAs and your NPs—I think they're going to have the ears and the wherewithal to be able to be your allies and colleagues in this. By and large, it's my APP colleagues and nursing that I talk to the most about this. … Again, it's not an easy thing to bring forward, having dilators in place. But I will tell you in the department that I work in, it was me and couple of nurses who pushed this issue with the physicians for two years and finally got it put in place. It can be done. There's a lot more centers out there doing that." TS 21:51

The hosts talk live to an audience of ACE Fellows about the White House's new proposal to rewrite the rulebook that governs how campuses manage federal grant funds, along with other higher education policy developments we're watching this summer. Here are some of the links mentioned in this week's show: Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards Department of Education https://www.ed.gov/grants-and-programs/manage-your-grant/uniform-administrative-requirements-cost-principles-and-audit-requirements-for-federal-awards-us-department-of-education Office of Management and Budget Proposed Rule on Uniform Guidance Federal Register | May 29, 2026 https://www.federalregister.gov/documents/2026/05/29/2026-10817/regulation-for-federal-financial-assistance White House Aims to Establish Political Oversight of Federal Grants Inside Higher Ed | May 29, 2026 https://www.insidehighered.com/news/government/science-research-policy/2026/05/29/omb-proposes-rules-establishing-political Negotiators Pass Draft Rules to Overhaul College Accreditation  ACE | May 22, 2026 https://www.acenet.edu/News-Room/Pages/Draft-Rules-Passed-to-Overhaul-Accreditation-.aspx

In this episode of the InspirED Podcast, Andrea De La Cerda sits down with Dr. Shenetta Malkia for a powerful conversation about financial independence, healing, identity, and purpose. Together, they explore how childhood conditioning, limited beliefs, relationships, financial abuse, and societal expectations can keep women disconnected from their voice and power. Dr. Shenetta shares her personal journey through suicide attempts, domestic violence, entrepreneurship, and faith, while offering practical tools for rebuilding confidence, reclaiming financial stability, and stepping into authentic purpose. This episode is a deeply honest conversation about resilience, healing, wealth, and creating a life that feels truly aligned....CHAPTERS00:00 Breaking Out of Limiting Beliefs05:32 Dr. Shenetta's Journey Into Real Estate and Entrepreneurship09:12 Suicide Survival, Mental Health, and Healing17:56 Reclaiming Your Voice and Identity20:24 Financial Independence and Financial Abuse30:05 Taking Your Power Back35:16 Faith, Purpose, and Personal Alignment46:32 Compassion, Healing, and Letting Go51:18 Leaving Unhealthy Situations and Rebuilding53:10 Advice to Her Younger Self and Final EncouragementRESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dr. Shenetta MalkiaThe Resilient Asset (her book)Sable Edge RealtyInstagram⁠⁠⁠⁠Andrea De La CerdaBusiness Audit⁠⁠⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Cameron is joined by Jenny Hartley, owner of the first accredited MedSpa through QUAD A, and they discuss the significance of accreditation in the medical aesthetics industry, focusing on patient safety, compliance, and the operational challenges that come with achieving accreditation. Jenny shares her journey, the importance of establishing standards, and how accreditation can serve as a competitive advantage for practices. They also touch on the evolving nature of aesthetics towards a healthcare model, the cultural shift within practices post-accreditation, and the importance of sharing knowledge to elevate industry standards.Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:Accreditation is a significant step for MedSpas.Patient safety tracking is crucial for the industry.There is a need for more regulation in aesthetics.Accreditation can enhance patient trust and safety.The aesthetics industry is evolving towards healthcare.Medical compliance is essential for practice owners.Team involvement is key to successful accreditation.Sharing resources can help elevate industry standards.Time is a valuable asset for practice owners.Practices should start by reviewing accreditation standards.Medical Millionaire: The Blueprint for Scaling a World-Class Medical Aesthetics PracticeWelcome to Medical Millionaire, the go-to podcast for forward-thinking Medspa owners, Medical Aesthetics leaders, Plastic Surgery & Dermatology practices, Concierge Wellness clinics, and Elective Healthcare entrepreneurs who are ready to scale with intention and operate like a true, high-performing business.If you're building, growing, optimizing, or preparing to exit your aesthetics or wellness practice, this show is your competitive advantage.Hosted by Cameron Hemphill Your Guide to Sustainable, Scalable Growth Your host, Cameron Hemphill, is one of the most trusted growth strategists in Medical Aesthetics and Elective Wellness.With over 10 years in the industry, Cameron has helped scale 1,000+ practices and more than 2,300 providers, working alongside the most recognized KOLs, national brands, EMRs, tech companies, and private equity groups, shaping the future of aesthetics. From marketing to operations, from finance to leadership, Cameron brings a real-world, data-driven perspective on what it takes to turn a practice into a powerful business engine.What This Podcast Is All About: Each episode takes you behind the scenes of the fastest-growing practices in the country, revealing the systems, strategies, and mindset required to win in today's Medical Aesthetics landscape.Expect tactical insights, step-by-step frameworks, and conversations with:Industry thought leadersTop injectors & medical directorsEMR & tech innovatorsOperations expertsMarketing strategistsPrivate equity & M&A advisorsWellness and longevity pioneersThis is where aesthetics, business, technology, and wellness converge. What You'll Learn on Medical Millionaire Every week, you'll access expert guidance to help you scale profitably and predictably, including:Marketing & Brand PositioningCRM + Lead Management SystemsPatient Acquisition & ConversionEMR Optimization & Tech Stack ArchitectureSales Psychology & Consultation MasteryFinance, KPIs, and Practice EconomicsOperational Workflows & AutomationIndustry Trends Backed by Real Benchmark DataPatient Retention & Lifetime Value ExpansionMindset, Leadership & Team DevelopmentWhether you're opening your first location or running a multi-million-dollar enterprise, you'll gain the clarity and direction to grow with confidence. A Show Designed for Every Stage of Practice Growth Medical Millionaire breaks down the journey into four essential stages, showing you exactly how to move from one to the next:Startup – Build the foundation and attract your first wave of patientsGrowth – Scale revenue, expand services, and strengthen operationsOptimize – Increase efficiency, margins, and customer experienceExit – Prepare your practice for maximum valuation and acquisitionIf You're Ready to Grow, This Is Where You Start. Tune in weekly for actionable insights, expert interviews, and the exact playbooks high-performing practices use to dominate their markets. This is the podcast for Medspa owners who want more than a job; they want a scalable, profitable, industry-leading business. Welcome to Medical Millionaire.Let's build your practice into the empire it deserves to be.

"There are a lot of specifics that nurses need to keep in mind as they are administering this herpes simplex modified virus to patients because accidental exposure is of concern both to the patient, to their family members, as well as to healthcare workers. I always recommend nurses wear personal protective equipment, such as a gown, safety glasses, gloves, and/or a face shield," Heidi Finnes, PharmD, RPh, BCOP, director of clinical ambulatory practice at Mayo Clinic and assistant professor of pharmacy at Mayo Clinic Alix School of Medicine in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about oncolytic viral therapy.  Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 29, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of oncolytic viruses to treat cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 273: Updates in Chemotherapy and Immunotherapy ONS Voice articles: Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy Oncolytic Virus Kills Tumor Cells While Supporting T Cells What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma Clinical Journal of Oncology Nursing articles: Intralesional Therapy: Consensus Statements for Best Practices in Administration From the Melanoma Nursing Initiative Safe and Effective Standards of Care: Supporting the Administration of T-VEC for Patients With Advanced Melanoma in the Outpatient Oncology Setting Oncology Nursing Forum article: Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma ONS book: Guide to Cancer Immunotherapy (second edition) ONS clinical practice resource: Safe Handling of Oncolytic Viruses ONS Huddle Card: Immunotherapy Association of Community Cancer Centers (ACCC) Drugs@FDA Hematology/Oncology Pharmacy Association (HOPA) Network for Collaborative Oncology Development and Advancement (NCODA) Patient Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "[Oncolytic viruses] can have direct lysis to the tumor cells themselves, or they can cause immunogenic activation. They release tumor-associated antigens and then proinflammatory signals, so think of T cells, natural killer cells, those sorts of things, that can convert to immunologically cold tumors. Those are tumors that are immune silenced into hot tumors which are now immune activated. By doing that, they recruit those T cells and other cells to the area to attack both the primary tumors. But that's also thought to be how they work on distant or noninjected sites as well. This immunomodulatory capacity has led to the reclassification of oncolytic viruses as a form of cancer immunotherapy. So, think of it kind of similarly to how we think of immune checkpoint inhibitors in recruiting immune cells and leaving our immune system in the on position. This is also kind of a form of immunotherapy." TS 4:35 "One of the toxicities I know that is of significant concern to patients, family members, and healthcare workers is the incidence of herpes infections. Systemic herpetic infections are extremely rare and usually more common in patients who may be immunocompromised. In patients who also have other immune-related diseases—such as vitiligo, vasculitis, pneumonitis, sometimes worsening psoriasis—because you're mounting an immune response with these types of things, sometimes you can see a worsening of those types of immune symptoms. But for the most part, these types of side effects are very well tolerated in most patients." TS 9:07 "Talimogene is generally transmitted via bodily fluids or touch. It's not airborne. Herpes simplex virus isn't an airborne type of virus. Another thing to consider is where are you going to inject this? Are you going to do this in your infusion therapy unit? Are you going to do it in a dedicated room? Who's going to escort the patient to the room? How is the virus going to arrive at the room? How will you clean the room and all of the laboratory equipment or any of the exam tables that may be in there? I think having all of that discussed and assigned mitigates the consternation that can sometimes occur—the fear that occurs with administering a virus that is thought to be fairly communicable." TS 15:44 "Helping patients understand how this works [is important] because hearing that you're receiving a virus, particularly a herpes simplex virus, can be scary to a patient. I think understanding that it's modified or essentially we're taking the parts out of it so that we can directly inject a portion that recruits immune cells to that area, because the goal is for the oncolytic virus to attack cancer cells and then destroy them by triggering an immune response in the body." TS 20:51 "Sometimes patients are very concerned about urine in the toilet, bodily fluids, kissing loved ones, holding hands, hugging, you know, am I going to infect my loved one because I'm getting this type of an oncolytic virus therapy? I like to reassure patients that they can continue to hold hands and hug their loved ones as normal. Viral DNA is usually only present on the injection site. And as I mentioned previously, we want to cover that injection site with an occlusive dressing, at least with talimogene, for up to seven days. And particularly, if those injection sites are at all oozing or weeping, active virus is usually only on that injection site itself." TS 24:14

In this episode of the InspirED Podcast, Andrea De La Cerda challenges the idea that women should be able to “have it all” at the same time without sacrifice or tension. She explores how modern expectations around career, motherhood, relationships, wellness, and success have created unsustainable pressure for women, often leading to burnout, fragmentation, and guilt. Through personal experience and research-backed insights, Andrea reframes success through the lens of alignment and seasons, encouraging women to stop measuring themselves against impossible standards and instead make intentional choices based on what matters most in the current season of life....CHAPTERS00:00 The Pressure to Have It All02:18 Why Modern Expectations Are Unsustainable05:04 The Hidden Cost of Trying to Do Everything07:49 Redefining Success Through Seasons11:08 The Power of Trade-Offs and Intentional Choices14:10 Alignment vs External Validation17:02 Building a Life That Feels Like YoursRESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

CAPRA accreditation sets the national standard for excellence in parks and recreation and agencies that go through the process are really committing to operating at the highest level across everything they do. From strengthening day-to-day operations to helping agencies plan for the future, CAPRA accreditation plays an important role in delivering the best possible services to our communities. On the latest episode of Open Space Radio, we explore how CAPRA accreditation is shaping park and recreation agencies, leadership and communities across the country. We also dive into how the newly reimagined 2027 CAPRA standards are helping make accreditation more adaptable and accessible for agencies of all sizes. Joining us for the conversation are three leaders with deep experience in the CAPRA process: Janet Bartnik, director of parks and recreation for Prince William County, Virginia, and member of the CAPRA standards reimagination team (and currently serving as deputy chief transformation officer for the Prince William County Transformation Management Office) Chris Bass, director of parks and recreation for DeKalb County, Georgia, and former CAPRA Commission chair Ray Bivens, director of recreation and parks for St. Mary's County, Maryland, and current CAPRA Commission chair Together, they share insights on what CAPRA accreditation looks like in practice, how it shapes agency culture and leadership, and why it should be viewed as more than just a checklist or designation. Tune in to the full episode below to learn: How CAPRA accreditation helps agencies build a culture of continuous improvement Why the updated 2027 standards are designed to be more flexible and adaptable for agencies of all types The unexpected benefits of accreditation, from staff development to recruitment and retention How accredited agencies use CAPRA standards in their day-to-day operations, not just during accreditation reviews And much more! Ready to experience the power of CAPRA? Check out The Power of CAPRA Accreditation to access a helpful toolkit so you can make the case for CAPRA within your organization. And, from May 20 through July 31, 2026, agencies beginning the CAPRA accreditation process will receive a waived application fee — a $130 value. To qualify, agencies must submit their CAPRA application and complete the checkout process by July 31, 2026. This season of Open Space Radio is sponsored by BCI Burke Outdoor play creates opportunities for connection, creativity and growth. At BCI Burke, they design play environments that inspire exploration and support the high standards park and recreation professionals strive for — including CAPRA accreditation — helping create spaces where everyone feels welcome to move, play and belong. Learn more at bciburke.com  

"When you have benign conditions, we're actually treating 3 gray, so a significant difference [versus doses of 60 gray for brain cancer]. Typically, when you treat at a high dose, the goal is to destroy tissue, like cancer tissue or cancer cells. But when we give a low dose, the goal is actually to modulate inflammation. And what it does is it slows down those inflammatory cells or those cells that release the chemicals that cause pain and inflammation," Amanda Meyer, DNP, APRN, CNP, family nurse practitioner in the Department of Radiation Oncology at the Mayo Clinic in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation therapy for noncancer indications. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 22, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of radiation to treat noncancerous conditions. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 365: Radiation-Associated Secondary Cancers Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices ONS Voice articles: Augmented Reality Simulations Reduce Patient Anxiety by Teaching Them About Radiation Therapy Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education Quick Quiz: Test Your Knowledge of Radiation Care Coordination ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS Radiation Oncology Conference Recordings Bundle™ ONS ROCN™ Certification Review™ Radiation Oncology 101: 2024 ONS Bridge™ Session ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Findings From the 2023 Radiation Oncology Nursing Role Delineation Study to Shape the Future of the Subspecialty The Role of Advanced Practice Providers in Radiation Oncology in 2025 ONS Huddle Cards: Radiation Radiobiology German Society for Radiation Oncology (DEGRO): Guidelines in Radiotherapy: Radiotherapy for Benign Diseases To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We always typically think of it as cancer treatment, but we can use radiation for noncancerous conditions, as well. And radiation was actually used for benign diseases right after the discovery of x-rays. By the 1920s it was used a lot for different types of musculoskeletal, dermatologic issues, and different types of inflammatory conditions. And over time, since the 1920s, we've actually really gotten a really good understanding of it." TS 1:37 "When we're looking at what are good candidate characteristics, we do typically like older patients, so patients over the age of 65. And the rationale behind that is we know that there is a potential for a secondary risk of a skin cancer about 20 to 30 years after getting low-dose radiation, like a basal cell or squamous cell skin cancer. The older the patient is, the less likely they are to have any adverse effects from that." TS 8:22 "When we do the low-dose radiation, they've tried other measures that haven't been successful. However, we don't want a patient who is so severe that they're ready for surgery, when they're bone on bone, because we know that radiation isn't as effective when they are that severe. So there's this sweet window where low-dose radiation works best in these patients." TS 9:39 "When we're treating with a little bit higher dose for like a Dupuytren's or a Ledderhose, because it's an anti-proliferative dose, those patients, they do get more skin redness, more dry skin. That's very temporary, and it resolves within a week or two after treatment. But really, we don't see any acute side effects. The long-term side effect of the radiation-induced malignancy, again, is a very low—0.05% according to some of the European guidelines." TS 12:34 "I really wish people appreciated how interdisciplinary this is. We need to get referrals from family medicine and from primary care and internal medicine and pain medicine physicians and inflammatory physicians and podiatry and pain specialists. And we really need to use this multidisciplinary approach to get earlier referrals for patients because there is this sweet window of time where low-dose radiation works the best." TS 18:40

In this episode of the InspirED Podcast, Andrea De La Cerda reframes imposter syndrome as a natural response to growth rather than proof of inadequacy. She explores the neuroscience behind visibility, fear, and self-protection, especially for women stepping into higher levels of leadership and expansion. Andrea breaks down the difference between fear and intuition, explains why confidence is built through action rather than certainty, and shares how to grow your capacity to be seen without shrinking yourself in the process. This episode offers a grounded perspective for high-achieving women navigating doubt while stepping into bigger opportunities....CHAPTERS00:00 Understanding Imposter Syndrome02:36 The Neuroscience of Visibility and Fear05:03 Distinguishing Fear from Intuition07:39 Embracing Doubt and Expanding Your CapacityRESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

What happens when a successful med spa owner realizes the industry's biggest challenge isn't competition—it's education? In this episode of Medical Spa Insider, AmSpa founder Alex Thiersch sits down with Tracy Olson, owner of Youthopia Med Spa and founder of Aesthetic Injector Academy, to discuss her unconventional journey from banking and finance into medical aesthetics—and why she chose to build an educational platform instead of expanding into multiple locations. Drawing from years of hiring, training, and managing injectors, Tracy shares the gaps she repeatedly saw in foundational education for new providers: limited anatomy training, inconsistent safety education, and a lack of standardized preparation before hands-on injecting. The conversation explores the realities of growing a med spa in an increasingly competitive market, why more locations don't always equal greater success, and how strong metrics—from utilization rates to retention and KPIs—can guide better business decisions. Discussion points include: Introduction and Background (0:40) Industry Growth and Challenges (2:33) Creation of Aesthetic Injector Academy (5:09) Business Decisions and Expansion (8:30) Educational Approach and Accreditation (10:17) Need for Basic Training in the Industry (17:37) Marketing and Outreach Efforts (24:14) Legal Challenges and Future Plans (29:54)

Sarah Parshall Perry of Defending Education joins Freedom to Learn for a fast-moving conversation on the biggest legal and policy fights in education today. We cover the launch of Defending Education's new litigation center, the power of accrediting bodies like the American Bar Association, and what's at stake for free speech and parental rights in […]

This accredited continuing education program is supported by an educational grant from Blueprint Medicine. It provides timely and practical education on systemic mastocytosis (SM). To obtain CME credit, visit https://checkrare.com/learning/p-systemic-mastocytosis-recognition-diagnosis-and-clinical-management/SM is a rare, chronic disorder driven by aberrant mast cell accumulation across multiple organ systems. Although diagnostic criteria are well established, a recent natural history study found that the average time to diagnosis is nearly five years. This prolonged delay—largely due to limited awareness of SM and its early symptoms—often results in unnecessary disease progression and inappropriate treatment. To address this clinical gap, this activity, led by Daniel J. DeAngelo, MD, PhD, Chief, Division of Leukemia at the Dana-Farber Cancer Institute, Harvard Medical School, in Boston, MA, provides an overview of the early signs and symptoms of SM, outlines the appropriate diagnostic criteria and tools, and reinforces the importance of timely referral and testing for these patients to be properly managed. Led by a clinical expert with experience diagnosing and treating patients with SM, this 45-minute CME program will highlight early signs of SM, outline diagnostic criteria and tools, and reinforce the importance of timely referral/testing. Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in hematology, dermatology, gastroenterology, immunology, and family practice. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the early symptoms of systemic mastocytosis and its clinical relevance.Apply best practices to diagnose systemic mastocytosis more efficiently.FacultyDaniel J. DeAngelo, MD, PhDChief, Division of LeukemiaDana-Farber Cancer Institute,Harvard Medical SchoolBoston, MADisclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. DeAngelo discloses the following relevant financial relationships with ineligible companies:Consultant: Amgen, Autolos, Blueprint Medicines, Incyte, Jazz, Novartis, Pfizer, and Takeda Research Support: AbbVie, Glycomimetics, Novartis, and Blueprint MedicinesData Safety Monitoring Board: Daiichi-SankyoOther Planners for this activity have no relevant financial relationships with any ineligible companies.This activity will review off-label or investigational information.The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation.There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days.PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2026. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

"We want to make sure that we discuss the details of the treatment and what treatments there are, whether it's an oral drug, whether it's a subcutaneous injection or an IV injection, [the patient's] potential for responding, whether this treatment is curative or supportive, and what the number of visits are. All of those different pieces of information that go into the decision-making process are really important," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN®, nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about myelodysplastic syndrome (MDS) treatment considerations. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 15, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the treatment considerations for MDS. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses Episode 256: Cancer Symptom Management Basics: Hematologic Complications ONS Voice articles: FDA Approves Luspatercept-Aamt for Anemia in Adults With MDS Infection Prevention for Oncology Nurses Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents Whole-Genome Sequencing May Guide Treatment Choices for AML and MDS Clinical Journal of Oncology Nursing articles:  Reducing Effects of Hospital-Associated Deconditioning in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy Targeted Drug Therapies: Beyond Blood Counts and Chemistries Oncology Nursing Forum article: Frailty in Patients With Hematologic Malignancies and Those Undergoing Transplantation: A Scoping Review ONS books:  BMTCN™ Certification Review Manual (second edition) Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice (third edition) ONS course: Hematopoietic Stem Cell Transplantation™ ONS Learning Library: Hematology, Cellular Therapy, and Stem Cell Transplantation ONS Symptom Intervention resources: Prevention of Infection: General Prevention of Infection: Transplant Aplastic Anemia and MDS International Foundation: MDS Drugs and Treatments Blood Cancer United: MDS Treatment HealthTree Foundation Myelodysplastic Syndromes Foundation To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The goals that I try to consolidate to make sure they're consistent with the patient's goals are to improve their counts, especially the anemia or cytopenias. If they're getting blood transfusions, we want to reduce the number of transfusions that they receive because we know that's linked to reduced overall survival, and it really impacts quality of life. ... And then for high-risk patients, it's a more serious discussion because we know that they are the ones who can progress to acute myeloid leukemia (AML). And we're trying to delay progression to AML. That means we're trying to improve their survival and we're also trying to manage their cytopenias and decrease their infection risk." TS 2:28 "If we look at approvals for low-risk disease and high-risk disease, those were really made based on the Revised International Prognostic Scoring System (IPSS-R) and sometimes the International Prognostic Scoring System (IPSS). Under those classification systems, when we think of lower-risk MDS, we think of patients who are primarily anemic but don't have increased blasts in their bone marrow. ... For higher-risk MDS, we want to have that discussion with those patients because their life expectancy is much shorter than patients with lower-risk MDS. We want to see if hematopoietic stem cell transplant would be something that they would be interested in if they don't have a lot of comorbidities and are relatively healthy." TS 11:41 "There are a lot of things to consider—[patients'] blood counts, comorbidities, whether they're frail, and what their goals are. There are some patients where there's no way they would want to go through transplant. And some patients want to be cured, so it just depends on your patient." TS 14:22 "I think of hematopoietic allogeneic transplants as a treatment for more of the patients with higher-risk MDS. ... With the Molecular International Prognostic Scoring System (IPSS-M), a patient can have pretty good blood counts and not have increased blasts in the bone marrow. You could send them for a transplant referral upfront without having to give them additional treatment. ... There is a recent publication that said if a patient doesn't have more than 10% blast, you could refer to transplant as a first option. ... Also, if you had a lower-risk patient who is relatively young and doesn't have any other treatment options, this would also be a patient that you could refer to transplant to see if we could care for them, and then they wouldn't have to be getting transfused all the time." TS 21:12 "I think that we often think low-risk, no treatment needed, but it depends on the person. They often need ongoing supportive care to manage their symptoms even if they're not getting treatment. And just because we're not treating them, active observation, bringing them in to see how they're doing, if they've had infections, if their blood counts are changing, that is paying attention to them and doing something. Just because they're low-risk doesn't mean they don't need anything and we can just schedule for a one-year follow-up." TS 26:30

About this episode: In this episode of the Wellness Pro Show, Cate Stillman sits down with Carey Peters, Co-Founder of Health Coach Institute (HCI), for the most candid conversation about certifications the wellness industry rarely gets to hear. Carey has spent more than two decades training tens of thousands of coaches across more than 50 countries, building and successfully exiting one of the largest coach training organizations in the world, and now mentoring founders and executives at the highest level of their careers. Her perspective on when a certification is the smartest investment you will ever make, and when it is simply a very expensive form of procrastination, is hard-won, deeply practical, and refreshingly direct. This conversation traces Carey's unlikely journey from working actress to accidental entrepreneur, through the creation of Holistic MBA and then Health Coach Institute, all the way to a multi-million dollar exit in 2023. Along the way she shares the inside story of how HCI scaled rapidly by marrying a powerful coaching methodology with sophisticated lead generation, what happens to a founder's vision when private equity enters the picture, and what she now knows about building something that lasts. For wellness professionals weighing their next investment, whether that is enrolling in a program, creating their own certification, or building a membership-based business model, this episode offers the clearest and most honest framework available for making that decision well. Key Takeaways: The Certification Collecting Trap: Why endless training can become a comfortable and costly form of avoidance, and how to recognize when that is what is happening The Green Light for Creating Your Own Certification: Why the signal to build your own program is not a methodology in your mind but proven results with real clients who are already asking you to teach them what you do Accreditation in Context: What bodies like ICF and the National Board of Health and Wellness Coaches actually mean for your business, and how to evaluate their value specifically for your audience at point of sale Confidence Comes From Doing: Why every coaching school produces graduates who struggle with confidence, and why the only real cure is working with more clients, not enrolling in more programs The Business Model is the Differentiator: Why for practitioners who already have a stack of credentials, a sustainable business model moves the needle far more than another certification ever will What Private Equity Does to a Founder: The honest account of what changes when outside investors or buyers enter a coaching business, and what founders need to know before they take that path Resources and Links: Carey Peters Website: https://careypeters.com Health Coach Institute: https://www.healthcoachinstitute.com Wellness Pro Hotline: https://api.leadconnectorhq.com/widget/bookings/wellness-pro-hotline Wellness Pro Academy: https://wellnesspro.academy Yogahealer: https://www.yogahealer.com About the Guest, Carey Peters: Carey Peters is the Co-Founder of Health Coach Institute, one of the world's leading health and life coach training programs, where she helped train tens of thousands of coaches across more than 50 countries. A Master Health and Life Coach, speaker, and trusted business mentor, Carey spent more than two decades teaching coaches how to deliver real transformation and build sustainable, profitable practices. She now works at the executive level with founders and leaders navigating their next chapter. About the Host, Cate Stillman: Cate Stillman is an Ayurvedic practitioner, author, and founder of Yogahealer and Wellness Pro Academy. For more than two decades she has helped wellness professionals build thriving membership communities rooted in ancient wisdom and innovative structure. She is the author of Body Thrive, Master of You, Uninflamed, and Primal Habits. Wellness Pro Academy: https://wellnesspro.academy Yogahealer: https://www.yogahealer.com Primal Habits: https://amzn.to/3OvfPOx Uninflamed: https://amzn.to/3UUBgJ2 Body Thrive: https://amzn.to/3udNFR0 Master of You: https://amzn.to/3OlfoGn   What would shift in your practice if you stopped waiting to feel ready, and started treating your next client session as the only certification that actually matters?

In this episode of the InspirED Podcast, Andrea De La Cerda explores what it really means to build a business that supports your life instead of consuming it. Drawing from personal experience, she shares how growth without systems, delegation, and boundaries can quickly turn entrepreneurship into exhaustion. Andrea breaks down the difference between building freedom versus building dependency, explains the founder's trap many entrepreneurs face, and offers practical insight on creating sustainable growth through intentional structure, aligned leadership, and smarter business design. This episode is a grounded conversation for entrepreneurs who want to scale without sacrificing their lives in the process....CHAPTERS00:00 When Success Starts Feeling Heavy02:18 Why Work-Life Balance Often Fails Entrepreneurs04:46 Building a Business That Depends on You07:32 Systems Create Freedom10:01 Delegation and the Founder's Trap13:06 Why Boundaries Protect Your Business15:32 Can Entrepreneurs Work Less?18:02 Building a Business That Supports Your Life RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Send us Fan MailAccreditation in law enforcement can feel like a four-letter word, especially when you've only experienced it as paperwork dumped on patrol. We talk with Kevin Rhea, co-founder and executive director of the National Association for Accreditation Leadership, to make the case that accreditation can be a leadership tool, not a compliance treadmill, when it's used to build systems that protect officers and earn community trust. We get practical about what “best practices” actually means, who sets those standards through CALEA and state programs, and why local community expectations still matter. Kevin explains how strong policy is meant to define acceptable behavior and reduce legal exposure, and why inconsistent policy enforcement is where agencies get into trouble. We also discuss the post-2020 policy climate, how DOJ grant incentives can shape use of force decisions, and why optics can drive outcomes even when officers are using trained techniques. Then we go where most conversations avoid: DOJ pattern and practice investigations and federal consent decrees. Kevin shares what he saw as Phoenix worked through accreditation during an ongoing investigation, and we break down the costly incentives that can keep consent decree monitoring alive for years. We close with why the accreditation manager role deserves to be professionalized, how better report writing and driver training can lower risk and even reduce costs, and where accreditation is headed next, including emerging standards like AI use in policing. If you want smarter conversations about police leadership, public safety standards, and accountable policing, subscribe, share this with a leader in your agency, and leave a review so more people can find the show. What part of accreditation do you think helps most, and what part needs to change?Join Our Tribe of Courageous Leaders:Get The BookGet Weekly Articles by Travis YatesJoin Us At Our WebsiteGet Our 'Courageous Leadership' TrainingJoin The Courageous Police Leadership Alliance

In this video, we're breaking down why Accreditation is becoming one of the smartest moves entrepreneurs can make for their programs and courses. From building instant credibility and buyer trust to positioning yourself as a true authority in your industry, we're covering how Accreditation can elevate your brand, increase confidence in your offers, and help your business stand out in a crowded online space. If you're serious about growing your authority and creating a more professional, trusted brand, this is a conversation you need to hear.✅ ACOP: https://bit.ly/Accreditation-Council-for-Online-Programs✅ Business audit: https://forms.gle/dWKUCJcaJMFP5jHe8Join The Vault & get instant access to 125+ courses, monthly LIVE Q&A sessions, monthly accountability calls, thousands of Canva Templates, new courses added throughout the year, and so much more! https://bit.ly/TheOfficialVaultGrab your FREE copy of my book, ‘Boss It Up Babe!'https://bit.ly/BOSSItUpBabeBookHost Bio:Kimberly Olson is a self-made multi-millionaire and the creator of The Goal Digger Girl, where she serves female entrepreneurs by teaching them simple systems and online strategies in sales and marketing. Through the power of social media, they are equipped to explode their online presence and get real results in their business, genuinely and authentically. She has two PhDs in Natural Health and Holistic Nutrition, has recently been recognized as the #2 recruiter in her current network marketing company globally, is the author of four books including best-sellers, The Goal Digger and Balance is B.S., has a top 25 rated podcast in marketing and travels nationally public speaking. She is a mom of two and teaches others how to follow their dreams, crush their goals and create the life they've always wanted.Website: www.thegoaldiggergirl.comInstagram: www.instagram.com/thegoaldiggergirlFacebook: www.facebook.com/thegoaldiggergirlYoutube: www.youtube.com/c/thegoaldiggergirlCheck out my Facebook groups for those that want to build their business online through social media, in a genuine and authentic way:Goal Digging Boss Babes: https://www.facebook.com/groups/goaldiggingbossbabesLeave a review here: Write a review for The Goal Digger Girl PodcastSubscribing to The Podcast:If you would like to get updates of new episodes, you can give me a follow on your favorite podcast app.

"Skin reactions, such as redness, dryness, and just irritation of the skin, can occur. Since we're irradiating the lung, we can also cause a cough, and that's due to the inflammation from the radiation. Patients can also get esophagitis if the tumor that we're treating is close to the midline of the chest near the esophagus. And probably the most common side effect that we see is fatigue," ONS member Amy MacRostie, RN, OCN®, radiation oncology nurse at St. Charles Cancer Center in Bend, OR, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radiation side effects in lung cancer. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 8, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the side effects of radiation to treat lung cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 369: Lung Cancer Survivorship Considerations for Nurses Episode 363: Lung Cancer Treatment Considerations for Nurses Episode 359: Lung Cancer Screening, Early Detection, and Disparities Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion ONS Voice article: Highly Localized, Precision Radiation Therapies Require Nurses to Drive Care Coordination, Patient Education ONS book: Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Radiation Therapy Certificate™ ONS ROCN™ Certification Review™ ONS Radiation Learning Library ONS Guidelines™ and Symptom Intervention Resources National Comprehensive Cancer Network LUNGevity Foundation Inspire Lung Cancer Survivors Community To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The types of radiation that can be used are external beam radiation and stereotactic body radiation treatment, or SBRT. External beam radiation is often used in combination with other treatment modalities, like chemotherapy, immunotherapy, and targeted therapy, to treat these cancers. And SBRT is usually done solo, and it's a highly precise treatment for inoperable or early-stage lung cancers." TS 1:52 "[Physicians and] providers can also help prevent side effects by reducing the dose to the heart and reducing the dose to the good lung tissue, if you will, as much as they possibly can. And this is done using intensity-modulated techniques, or IMRT. And that's where the linear accelerator sculpts the radiation beams conforming to the shape of the tumor itself." TS 6:37 "I think overall cancer treatment can lead to decreased libido and decreased sexual interest. Depression and fear can definitely play a role in this. And with lung radiation, specifically, fatigue and possibly shortness of breath with the exertion may decrease sexual interest. Nurses and providers should support the patient in their desire or lack thereof in sexual activities. We should have open discussions … and these can take place with patients about intimacy and how that can be approached in a different way that can accommodate for the side effects that the patients might be experiencing." TS 8:57 "Post-radiation scans will be abnormal. Post-radiation imaging can be misread as a progression of disease or residual disease. And I tell patients, 'Don't panic. Talk to your radiation oncologist so they can read the imaging themselves and interpret the results.' Oftentimes what's read as progression is radiation treatment sequela of scarring or fibrosis." TS 11:25

What happens when women stop just consuming information—and start applying it?In this episode, Andrea sits down with Jennifer Kornoely, founder of She Reads, She Leads, to explore the gap between learning and implementation. Together, they unpack why so many women are reading powerful books but still feel stuck, how community accelerates growth, and why conversations—not just content—are what create real change.They also dive into money mindset, business confidence, and the language women use that may be quietly holding them back. This conversation is both practical and eye-opening, especially for women building businesses or stepping into leadership.CHAPTERS00:00 Transitioning from Corporate to Entrepreneurship05:08 Challenges Faced by Women Entrepreneurs09:32 The Importance of Community and Conversation13:24 Building a Supportive Network17:58 Book Recommendations for Women Entrepreneurs21:47 Conclusion and Resources...RESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠⁠Book RecommendationsFinancial Feminist by Tori DunlapRich AF by Vivian TuGet Good with Money by Tiffany AlicheJennifer KornoelyShe Reads, She Leads Book Club → https://shereadssheleads.comTAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

Hello voices from the bench community, John Wilson here and I wanted to share some news about the evolution of the Programill lineup. Most importantly, Ivoclar's new PrograMill 7. What stands out right away is the reduced air consumption this mill requires, but what you'll notice first is that impressive new touchscreen. For us, the biggest advantage has been increased spindle power. My laboratory's known for these larger cases with complex geometries, and I can tell you that extra power really makes a difference. Next time you see your Ivoclar representative, be sure to ask about the PrograMill 7 and tell them John Wilson sent you. Thank you. At exocad Insights in beautiful Mallorca, we finally caught up with Felix from Imagine USA—and the timing couldn't have been better. As an exocad dealer on the front lines of digital dentistry, Felix shared his excitement about the strong turnout, the familiar faces, and most importantly, the innovation coming from exocad. What stood out most? The new exocad Hub and its cloud-based capabilities, along with powerful AI-driven tools inside DentalDB designed for efficient batch processing. For Felix and the Imagine team, it's not just about seeing what's new—it's about putting it to the test. By running new features through their own production facility first, they ensure real-world performance before bringing solutions to their customers. Beyond the technology, Felix emphasized the value of being there in person—connecting face-to-face with partners, having meaningful conversations, and stepping back to see where the industry is headed. And of course, doing it all in Mallorca doesn't hurt either. This episode finally brings a long-awaited conversation to life with Kent Kohli, a name many in the industry recognize—but maybe don't fully know the story behind. From an unexpected entry into dentistry (thanks to marrying his orthodontist's daughter) to becoming a lifelong student of ceramics and education, Kent's journey is anything but typical. What starts as a pre-dental path quickly shifts once Kent discovers the lab side of dentistry—and more importantly, where his passion truly lives. From pouring models and grinding metal to studying under legends like John Archibald, Kent shares how mentorship, curiosity, and relentless work ethic shaped his career. Along the way, he opens up about the early struggles—working 100-hour weeks, barely making ends meet, and choosing quality over the “race to the bottom” that burned out many of his peers. Kent dives deep into the evolution of dental technology, from the early days of PFMs and Empress to today's digital workflows and liquid ceramics. But at the heart of it all is a consistent theme: education. Whether it's learning from the “giants” of the industry or now helping guide the next generation through his role at Ivoclar, Kent sees it as a responsibility to pass on what was given to him. He also shares insights into his current mission—bringing hands-on education back to the forefront, blending traditional techniques with modern materials, and helping technicians elevate their craft beyond just production. Rising costs, tighter deadlines, and greater demands are challenging labs everywhere. When efficiency matters, you need tools that deliver—every day. Roland DGShape milling solutions are reliable and easy to use. Just turn them on and let them run—no babysitting required. Fewer remakes and less wasted material mean your team can focus on getting cases out the door. With the Elevate Denture solution, step into digital dentures without disrupting your workflow. Validated CAM strategies and Ivoclar compatibility mean you're building on a system you already trust. Ready to boost efficiency? Explore DG Shape DWX Milling Solutions and the Elevate Dental Solution at RolandDental.com.Special Guest: Kent Kohli.

"We thought, from a nursing standpoint, 'What is our goal for doing this?' What we wanted was first, education of the patient. Can we successfully educate the patient to prepare them? Can we alleviate as much anxiety as possible so that they feel comfortable coming in and having this done? The second goal is to preserve kidney function throughout the treatment. To date, we've been successful with that. And the third goal is to complete treatment without infection," ONS member Chris Amoroso, BSN, RN, OCN®, registered nurse at Fox Chase Cancer Center in Philadelphia, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about intrarenal administration for upper urothelial tract disease. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 1, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Nurses caring for people with cancer require knowledge of the different routes for drug administration, including intrarenal administration via a percutaneous nephrostomy. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 141: Care Coordination for Urothelial Cancer Episode 133: Treatment Advancements for Advanced or Metastatic Urothelial Cancer ONS Voice articles: A Primer on Urothelial Cancer Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage Nurses Are Key to Patients Navigating Genitourinary Cancers Clinical Journal of Oncology Nursing articles: Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial Carcinoma Percutaneous Nephrostomy Infusion: Nursing Considerations for Treatment of Upper Urinary Tract Urothelial Carcinoma ONS Learning Libraries: Cancer of the Genitourinary Tract Safe Handling of Hazardous Drugs To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "In an office setting, it's not something we can really visualize. Patients will present with hematuria or flank pain, obstructions in the ureter, some hydronephrosis, they may be having a lot of urinary tract infections. And a routine cystoscopy in the office is not going to visualize the ureters. We can do biopsies like a ureteroscopy, a computerized tomography urogram, or a urine cytology. And those are usually the main ways of diagnosing upper tract disease—again, because it's rare." TS 2:33 "We ask patients to get into a comfortable position where they can sit or lay for an hour without too much movement. The movement of their body position can interfere with the flow of the medication going in. ... When we're ready to start, we're cleaning the ends of the nephrostomy tube and the IV tubing with a chlorhexidine solution. We're instilling this using micro drip tubing. The tubing has to be microchipped so we can accurately control the flow. The IV bag with medication is hung about 10 inches above kidney level. And the reason we do that is because we do not want to increase the intrarenal pressure. ... We want a slow infusion via gravity over about an hour. We're watching throughout the procedure to make sure that there's no leakage, no discomfort, really just watching the patient and having that communication with the patient. Are they feeling anything different? Do we notice a difference in the flow rate? Is it slowing down? And if so, why is it? Did the patient change position? If we have any [instance] where the patient says, 'I can feel something there,' or we see leakage, we stop that infusion immediately, emphasizing that it has to be gravity, never on a pump." TS 7:30 "We go over all the bacillus Calmette-Guérin (BCG) precautions because this is the drug that we're giving. As if we were doing traditional intravesical therapy such as placing a catheter up into the bladder, we're still giving patients BCG. So, we need them to follow the special precautions. We ask every patient, regardless of the drug we're giving them, to sit down to urinate, pour two cups of bleach in the toilet, let it sit for about 15 minutes, then close the lid and flush twice. Even though we're giving this for upper tract disease, it's still being excreted into the urine. So, precautions need to be followed. Sitting down to urinate to avoid splashing of the drug, putting the two cups of bleach in every time they urinate for a duration of six hours, closing the lid, and then flushing that toilet twice. The same precautions, whether it's traditional intravesical or intrarenal." TS 14:20 "The induction phase is the first six installations. So, the first time we give this drug, we're doing it once a week for six weeks. And during those six weeks, we're communicating with the patient. We'll do a follow-up phone call and ask, 'How are you feeling? Any issues?' And we do get to know our patients really well. ... If they call, we're going to send them for a urine culture and make sure there's nothing there. ... After those six weeks, we make sure the patient understands that this is not one course and done. We want to continue to do this to give them the best chance at preventing recurrence. After we've done those six, we'll wait about four to six weeks, and then we'll do a cystoscopy and ureteroscopy in the operating room to make sure we have the response we're looking for. Again, letting the patients know because sometimes they don't understand that this is going to continue—it's not six treatments and done." TS 23:08 "You can't think of this as the same as bladder cancer. This is in the upper tract. We can't approach it as if it was non-muscular invasive bladder cancer. The diagnosis is different. It's harder to diagnose. Again, we're not visualizing the ureters in a routine office cystoscopy.  ... You can't resect it out. When I was talking to our surgeon, he said, 'You can't resect the urothelial disease in the ureters like you would in a bladder tumor.' You can't go and just pick it apart. It's a little bit more complex than that. You can't go in and resect out lesions in the ureter itself." TS 36:20

In this episode of the InspirED Podcast, Andrea De La Cerda challenges the traditional hustle-driven model of success and introduces a more sustainable, aligned approach to building a business. She explores the concept of feminine power in business—focusing on energy, intuition, and cyclical productivity rather than constant output. Through personal experience and research, Andrea explains why overwork leads to burnout and how integrating alignment, collaboration, and sustainability can lead to greater impact and long-term success....CHAPTERS00:00 – Rethinking success and constant pressure01:00 – When hustle culture stops working02:00 – Masculine vs feminine business models03:00 – The cost of overwork and burnout04:00 – Where clarity and best ideas come from05:00 – The feminine business blueprint06:00 – Working with your energy and cycles07:00 – Intuition as a strategic advantage08:00 – Collaboration vs doing it all alone09:00 – Redefining success and sustainability10:00 – Aligning your work with your energy11:00 – Building success without depletionRESOURCES ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Business Audit⁠⁠TAG ANDREA ON INSTAGRAM⁠⁠⁠⁠⁠@andreadlc_coach⁠⁠⁠CONNECT WITH KANDULA⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Kandula Blogs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. . .ABOUT ANDREA DE LA CERDAAndrea De La Cerda is a highly accomplished communications professional with over 25 years of experience in the fields of advertising, communications and marketing. Throughout her career, Andrea has held key positions in renowned advertising agencies, brand consultancies and in-house marketing departments before creating Kandula. She possesses a deep understanding of consumer behavior and market trends, allowing her to develop innovative communication strategies that resonate with diverse audiences. Andrea received both her B.A. in Advertising and Business Administration and a M.A. in Education from Pepperdine. She is currently pursuing her Accreditation in Public Relations and is a member of PRSA.. . .WORK WITH USKandula works with nonprofits, entrepreneurs, educational institutions, and established brands dedicated to expanding their influence and amplifying their impact through purpose-driven communication strategies. Reach out to work with us!

"They are small, powerful little nuggets. They are actually small signaling proteins that our immune cells use to communicate. They really help regulate immune activation or inflammation and even the growth and survival of immune cells. When cytokines are used therapeutically in oncology, they help to stimulate immune cells such as T cells or natural killer cells to better recognize and attack cancer cells," Maribel Pereiras, PharmD, BCPS, BCOP, clinical pharmacy specialist at the John Theurer Cancer Center of Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the cytokine drug class. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours (including 30 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 24, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Nurses caring for people with cancer require knowledge of cytokines to provide appropriate education and to safely administer related therapies. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis ONS Voice articles: FDA Approves Nogapendekin Alfa Inbakicept-Pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer Manage Cancer-Associated Anemia With Erythropoietin-Stimulating Agents Oncology Drug Reference Sheet: Motixafortide ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) and 2024 Drug Supplement Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Guide to Cancer Immunotherapy (second edition) Clinical Journal of Oncology Nursing article: Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Nursing Considerations What's Old Is New Again, Unfortunately ONS Symptom Interventions Colony-Stimulating Factors Including Biosimilars for At-Risk Patients for Prevention of Infection: General Platelet Growth Factors for Prevention of Bleeding National Comprehensive Cancer Network To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Cytokines are actually among some of the earliest forms of immunotherapy used in the treatment of cancer, and it really goes back to the 1980s and the 1990s. We're talking therapies like interferon [alpha] or interleukin-2 that were used to stimulate the immune system, with the idea that they would recognize and attack cancer cells, particularly in diseases like metastatic melanoma and renal cell carcinoma. What made these therapies unique was that although the overall response rates were relatively modest, when patients did respond, those responses could be very durable and sometimes long lasting. And that observation was really important for the field of oncology, because it was part of the process that demonstrated that the immune system could potentially control cancer in really meaningful ways." TS 1:49 "One nice new example of an engineered cytokine is nogapendekin alfa inbakicept, which is quite the tongue twister to say. … This agent is really interesting because it's an engineered interleukin-15 receptor agonist that works on stimulating natural killer cells and CD8-positive T cells. And what makes this so interesting is that it's used in combination with a medication that probably some of us are familiar with—good old BCG—for patients specifically with invasive bladder cancer. The other really interesting thing about this new therapy is the fact that it is one of our first ones to be engineered in a combination fashion. So the nogapendekin alfa is combined with a receptor component that is called inbakicept. And what happens is it forms a complex to enhance signaling and prolong the activity of the cytokine." TS 7:50 "When you're looking at our therapeutic cytokines, those tend to produce larger-scale systemic inflammatory effects leading to much more global side effect reactions, while your supportive care cytokines are more commonly associated with either bone marrow stimulation effects or hematologic changes." TS 14:01 "Regardless of what type of cytokine therapy may you be using, across the board, early recognition of the symptoms and proactive supportive care are really important. And this is where many of our oncology nurses play such a critical role in identifying changes that are happening in real time to the patient's condition and helping to coordinate, relay information to the rest of the providing team so that timely interventions can occur for the best care of the patient." TS 18:01 "The other fascinating thing about these cytokines is that they're not being used as monotherapy anymore. They're now being looked at in combination with other therapies or even other immunotherapies like our checkpoint inhibitors. They're being looked at in the sense that they may be able to help expand and further activate immune cells that our current therapies rely on. And so it's really interesting that while cytokines were some of the earliest forms of cancer immunotherapy, they're now being reimagined as part of modern combination strategies designed to really further help enhance the immune responses against cancer." TS 29:08

Today, the Safari visits Mystic Aquarium to talk to the chair and vice-chair of the AZA Accreditation Committee. What does accreditation mean? What does it look like? What happens when an AZA-accredited facility is accused of not living up to the gold-standard that AZA accreditation represents? Can accreditation be revoked? Can special circumstances be accounted for from facility to facility? We ask all this and more! EPISODE LINKS: mysticaquarium.org @mysticaquarium @bronxzoo bronxzoo.com @zoos_aquariums aza.org ROSSIFARI LINKS: Rossifari.com Patreon.com/rossifari to support the pod @rossifari on socials @rossifaripod on TikTok 

This episode recorded live at the Becker's 16th Annual Meeting features Dr. Shawn Griffin, CEO of URAC, who explores how healthcare organizations can build trust in AI through strong governance, ethical leadership, and independent accreditation. He also shares why holding both developers and health systems to consistent standards is critical as AI scales across care delivery.This episode is sponsored by URAC.